Marketing News

Galderma S.A. has gained full rights to distribute

Author Image

By: TOM BRANNA

Editor

Galderma S.A. has gained full rights to distribute Restylane, Perlane, Emervel, Sculptra and Dysport from Valeant Pharmaceuticals International, Inc. The expansion into aesthetic and corrective dermatology in the US and Canada completes Galderma’s global skin health footprint and extends its leadership in aesthetic medicine worldwide, the company said. “We at Galderma are delighted to bring Restylane, Perlane, Emervel, and Dysport home in the US and Canada as is the case in dozens of countries ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters